Location: Home
  • search
  • go
  • Relate News
  • 2/9/2010Shenzhen Weiwu Guangming Bio to build largest blood product facility i...
  • 2/9/2010Upcoming Event: China Pharmaceutical R&D Summit 2010
  • 2/8/2010China's Foreign Trade of Western Medicines in 2009 and Outlook for 201...
  • 2/8/2010Overview of the Chinese Vaccine Market 2006-2009
  • 2/8/2010MOH issues China’s first national formulary
  • 2/8/2010MOC encourages consolidation in the Chinese pharma distribution sector...
  • 2/8/2010Hengrui posts substantial revenue and net profit growth in 2009
  • 2/8/20103SBio licenses dialysis drug from Panacor
  • 2/8/2010BioMarin to acquire LEAD Therapeutics
  • 2/8/2010Hisun to acquire 4.5% stake in Sagent Pharma
  • 2/8/2010Pfizer initiates e-payment system in emerging markets
  • 2/5/2010MOH drafts a new hospital drug purchase tender guidelines amid rising ...
  • 2/5/2010China Biologic appoints a new independent director
  • 2/5/2010Gorbec Pharma opens GMP analytical laboratory in China
  • 2/4/2010MOH releases 2009 healthcare statistics
  • 2/4/2010Recent survey reveals medicine cabinets of Chinese families
  • 2/4/2010CNMA ranks leading OTC companies and brand names in 2009
  • 2/4/2010Foreign drug companies may lose exclusivity for some drugs in India
  • 2/4/2010New report highlights prospects and challenges of drug discovery in In...
  • 2/4/2010Pfizer delegation visits the Ministry of Health
  • 2/4/2010Pfizer hopes for faster growth in China
  • 2/4/2010Guangdong initiates hospital drug procurement following tender
  • 2/3/2010Spectrum licenses rights of cancer drug candidate for certain markets ...
  • 2/3/20102009 Judicial Interpretation Offer Guidelines for Applying Criminal La...
  • 2/3/2010The State Council approves public hospital reform plan
  • 2/3/2010China Population Association publishes survey findings on breast disea...
  • 2/3/2010Nanomed gains funding from SB China Venture Capital
  • 2/2/2010Chinese government to restructure funding scheme for the national esse...
  • 2/2/2010Guangzhou Huacheng Pharma completes phase III trials of class one cere...
  • 2/2/2010Pharmadule in China business deal with Morimatsu
  • Page:656/801 Total number of articles:24028: [First][<<] [654] [655] [656] [657] [658] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group